Critical Care (Aug 2020)

Adverse events associated with nafamostat mesylate and favipiravir treatment in COVID-19 patients

Toru Hifumi,
Shutaro Isokawa,
Norio Otani,
Shinichi Ishimatsu

Affiliations

Toru Hifumi: Department of Emergency and Critical Care Medicine, St. Luke’s International Hospital
Shutaro Isokawa: Department of Emergency and Critical Care Medicine, St. Luke’s International Hospital
Norio Otani: Department of Emergency and Critical Care Medicine, St. Luke’s International Hospital
Shinichi Ishimatsu: Department of Emergency and Critical Care Medicine, St. Luke’s International Hospital

DOI: https://doi.org/10.1186/s13054-020-03227-4
Journal volume & issue: Vol. 24, no. 1
pp. 1 – 2

Abstract

No abstracts available.

Published in Critical Care

ISSN: 1364-8535 (Print); 1466-609X (Online)
Publisher: BMC
Country of publisher: United Kingdom
LCC subjects: Medicine: Internal medicine: Medical emergencies. Critical care. Intensive care. First aid
Website: https://ccforum.biomedcentral.com/

About the journal